Literature DB >> 2544072

Neuropathy in IgM lambda paraproteinemia. Immunoreactivity to neural proteins and chondroitin sulfate.

W C Yee1, A F Hahn, S A Hearn, A R Rupar.   

Abstract

In axonal neuropathies associated with IgM paraproteinemia, reports of antigen specificity of the M-protein are few. A patient with IgM paraproteinemia presented with progressive mononeuritis multiplex. IgM was found deposited in striking amounts in endoneurium and shown to bind specifically to neural proteins and chondroitin sulfates. Direct immune mechanisms, as well as the physical effects of IgM deposition, likely contributed to the development of the neuropathy.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2544072     DOI： 10.1007/BF00687403

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


  27 in total

Review 1.  Peripheral neuropathy associated with monoclonal IgM autoantibody.

Authors:  A J Steck; N Murray; K Dellagi; J C Brouet; M Seligmann
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

2.  Waldenström's macroglobulinemia and peripheral neuropathy: deposition of M-component and kappa light chain in the endoneurium.

Authors:  C Vital; C Deminière; B Bourgouin; A Lagueny; B David; P Loiseau
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

3.  Peripheral polyneuropathy, high and low molecular weight IgM, and amyloidosis.

Authors:  D D Bigner; W H Olson; D E McFarlin
Journal:  Arch Neurol       Date:  1971-04

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis.

Authors:  C Meier; K Roberts; A Steck; C Hess; E Miloni; L Tschopp
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis.

Authors:  W H Sherman; N Latov; A P Hays; M Takatsu; R Nemni; G Galassi; E F Osserman
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

7.  Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy.

Authors:  P E Braun; D E Frail; N Latov
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

8.  Microangiopathy of vasa nervorum in dysglobulinemic neuropathy.

Authors:  H C Powell; M Rodriguez; R A Hughes
Journal:  Ann Neurol       Date:  1984-04       Impact factor: 10.422

9.  Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein.

Authors:  C Melmed; D Frail; I Duncan; P Braun; D Danoff; M Finlayson; J Stewart
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

10.  Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy.

Authors:  J F Poduslo; G L Curran; P J Dyck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205
View more
  8 in total

1.  Amyloid-like IgM deposition neuropathy: a distinct clinico-pathologic and proteomic profiled disorder.

Authors:  Juan J Figueroa; E Peter Bosch; P James B Dyck; Wolfgang Singer; Julie A Vrana; Jason D Theis; Ahmet Dogan; Christopher J Klein
Journal:  J Peripher Nerv Syst       Date:  2012-06       Impact factor: 3.494

2.  IgM cryoglobulin deposits in the peripheral nerve.

Authors:  A Vital; C Vital; J M Ragnaud; A Baquey; J Aubertin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.

Authors:  K B Yeung; P K Thomas; R H King; H Waddy; R G Will; R A Hughes; N A Gregson; S Leibowitz
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

4.  Axonal neuropathy associated with monoclonal gammopathy of undetermined significance.

Authors:  K C Gorson; A H Ropper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

5.  Polyneuropathy associated with IgA monoclonal gammopathy: a hypothesis of its pathogenesis.

Authors:  R Nemni; A Mamoli; R Fazio; M Camerlingo; A Quattrini; I Lorenzetti; M Comola; G Galardi; N Canal
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Immunotactoid-like endoneurial deposits in a patient with monoclonal gammopathy of undetermined significance and neuropathy.

Authors:  D F Moorhouse; R I Fox; H C Powell
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Repeated treatments with rituximab in a patient with amyloid-like IgM deposition neuropathy.

Authors:  Masato Kadoya; Akiko Kadoya; Hiroyuki Onoue; Katsunori Ikewaki; Jun Shimizu; Kenichi Kaida
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-03-31

8.  A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy.

Authors:  Jung-Lung Hsu; Ming-Feng Liao; Hui-Ching Hsu; Yi-Ching Weng; Ai-Lun Lo; Kuo-Hsuan Chang; Hong-Shiu Chang; Hung-Chou Kuo; Chin-Chang Huang; Long-Sun Ro
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.